These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 24296978

  • 1. Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.
    Wang H, Cui XX, Goodin S, Ding N, Van Doren J, Du Z, Huang MT, Liu Y, Cheng X, Dipaola RS, Conney AH, Zheng X.
    Oncol Rep; 2014 Feb; 31(2):835-41. PubMed ID: 24296978
    [Abstract] [Full Text] [Related]

  • 2. Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence.
    Zheng X, Cui XX, Gao Z, Zhao Y, Lin Y, Shih WJ, Huang MT, Liu Y, Rabson A, Reddy B, Yang CS, Conney AH.
    Cancer Prev Res (Phila); 2010 Jan; 3(1):114-24. PubMed ID: 20051379
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
    Xiao H, Zhang Q, Lin Y, Reddy BS, Yang CS.
    Int J Cancer; 2008 May 01; 122(9):2115-24. PubMed ID: 18172863
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.
    Ding N, Cui XX, Gao Z, Huang H, Wei X, Du Z, Lin Y, Shih WJ, Rabson AB, Conney AH, Hu C, Zheng X.
    Int J Oncol; 2014 Jun 01; 44(6):2139-45. PubMed ID: 24647860
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independence.
    Zheng X, Cui XX, Gao Z, Zhao Y, Shi Y, Huang MT, Liu Y, Wagner GC, Lin Y, Shih WJ, Rao CV, Yang CS, Conney AH.
    Exp Ther Med; 2011 Mar 01; 2(2):221-228. PubMed ID: 21660218
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma].
    Gao J, Li JS, Xu GL, Jia WD, Ma JL, Yu JH, Ge YS.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec 01; 18(12):900-4. PubMed ID: 21205474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
    Reddy BS, Wang CX, Kong AN, Khor TO, Zheng X, Steele VE, Kopelovich L, Rao CV.
    Cancer Res; 2006 Apr 15; 66(8):4542-6. PubMed ID: 16618783
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo.
    Abedinpour P, Baron VT, Welsh J, Borgström P.
    Prostate; 2011 Jun 01; 71(8):813-23. PubMed ID: 21456064
    [Abstract] [Full Text] [Related]

  • 19. The mechanism underlying vascular smooth muscle cell apoptosis induced by atorvastatin may be mainly associated with down-regulation of survivin expression.
    Xu YG, Zhou SH, Li YG, Zheng CH, Li XP, Liu QM, Xu DM, Chen S.
    Cardiovasc Drugs Ther; 2007 Jun 01; 21(3):145-53. PubMed ID: 17372815
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.